1
|
Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001.
|
Blood
|
2005
|
8.37
|
2
|
Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium.
|
Lancet Oncol
|
2006
|
4.13
|
3
|
Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinants.
|
Int J Cancer
|
2009
|
3.15
|
4
|
Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium.
|
Am J Epidemiol
|
2010
|
2.86
|
5
|
Etiologic heterogeneity among non-Hodgkin lymphoma subtypes.
|
Blood
|
2008
|
2.49
|
6
|
Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32.
|
Nat Genet
|
2010
|
2.37
|
7
|
Utility of methylation markers in cervical cancer early detection: appraisal of the state-of-the-science.
|
Gynecol Oncol
|
2008
|
2.08
|
8
|
Cytokine polymorphisms in the Th1/Th2 pathway and susceptibility to non-Hodgkin lymphoma.
|
Blood
|
2006
|
2.06
|
9
|
Risk of non-Hodgkin lymphoma (NHL) in relation to germline variation in DNA repair and related genes.
|
Blood
|
2006
|
2.02
|
10
|
Host and viral genetics and risk of cervical cancer: a review.
|
Virus Res
|
2002
|
1.97
|
11
|
Genome-wide association study of glioma and meta-analysis.
|
Hum Genet
|
2012
|
1.96
|
12
|
Hair dye use, genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma.
|
Carcinogenesis
|
2007
|
1.94
|
13
|
Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia.
|
Nat Genet
|
2013
|
1.85
|
14
|
Association of HLA class I and II alleles and extended haplotypes with nasopharyngeal carcinoma in Taiwan.
|
J Natl Cancer Inst
|
2002
|
1.79
|
15
|
Adulthood residential ultraviolet radiation, sun sensitivity, dietary vitamin D, and risk of lymphoid malignancies in the California Teachers Study.
|
Blood
|
2011
|
1.76
|
16
|
Predicting absolute risk of CIN3 during post-colposcopic follow-up: results from the ASCUS-LSIL Triage Study (ALTS).
|
Am J Obstet Gynecol
|
2006
|
1.69
|
17
|
Genetic variation and willingness to participate in epidemiologic research: data from three studies.
|
Cancer Epidemiol Biomarkers Prev
|
2005
|
1.66
|
18
|
Grading the severity of cervical neoplasia based on combined histopathology, cytopathology, and HPV genotype distribution among 1,700 women referred to colposcopy in Oklahoma.
|
Int J Cancer
|
2009
|
1.65
|
19
|
GWAS of follicular lymphoma reveals allelic heterogeneity at 6p21.32 and suggests shared genetic susceptibility with diffuse large B-cell lymphoma.
|
PLoS Genet
|
2011
|
1.58
|
20
|
Lack of evidence for human-to-human transmission of avian influenza A (H9N2) viruses in Hong Kong, China 1999.
|
Emerg Infect Dis
|
2002
|
1.54
|
21
|
Polymorphisms in DNA repair genes and risk of non-Hodgkin lymphoma among women in Connecticut.
|
Hum Genet
|
2006
|
1.47
|
22
|
Determinants of human papillomavirus load among women with histological cervical intraepithelial neoplasia 3: dominant impact of surrounding low-grade lesions.
|
Cancer Epidemiol Biomarkers Prev
|
2003
|
1.44
|
23
|
Mortality trends for cervical squamous and adenocarcinoma in the United States. Relation to incidence and survival.
|
Cancer
|
2005
|
1.35
|
24
|
Genetic variants in caspase genes and susceptibility to non-Hodgkin lymphoma.
|
Carcinogenesis
|
2006
|
1.32
|
25
|
Gene-nutrient interactions among determinants of folate and one-carbon metabolism on the risk of non-Hodgkin lymphoma: NCI-SEER case-control study.
|
Blood
|
2007
|
1.30
|
26
|
Histopathologic extent of cervical intraepithelial neoplasia 3 lesions in the atypical squamous cells of undetermined significance low-grade squamous intraepithelial lesion triage study: implications for subject safety and lead-time bias.
|
Cancer Epidemiol Biomarkers Prev
|
2003
|
1.29
|
27
|
Host immune gene polymorphisms in combination with clinical and demographic factors predict late survival in diffuse large B-cell lymphoma patients in the pre-rituximab era.
|
Blood
|
2008
|
1.26
|
28
|
Genetic polymorphisms in the oxidative stress pathway and susceptibility to non-Hodgkin lymphoma.
|
Hum Genet
|
2006
|
1.24
|
29
|
Association of HPV16 E6 variants with diagnostic severity in cervical cytology samples of 354 women in a US population.
|
Int J Cancer
|
2009
|
1.22
|
30
|
Human papillomavirus (HPV) genotyping using paired exfoliated cervicovaginal cells and paraffin-embedded tissues to highlight difficulties in attributing HPV types to specific lesions.
|
J Clin Microbiol
|
2007
|
1.22
|
31
|
A putative exonic splicing polymorphism in the BCL6 gene and the risk of non-Hodgkin lymphoma.
|
J Natl Cancer Inst
|
2005
|
1.20
|
32
|
Socioeconomic status and the risk of cervical intraepithelial neoplasia grade 3 among oncogenic human papillomavirus DNA-positive women with equivocal or mildly abnormal cytology.
|
Cancer
|
2005
|
1.19
|
33
|
Polymorphisms in apoptosis and cell cycle control genes and risk of brain tumors in adults.
|
Cancer Epidemiol Biomarkers Prev
|
2007
|
1.17
|
34
|
Risk of non-Hodgkin lymphoma associated with germline variation in genes that regulate the cell cycle, apoptosis, and lymphocyte development.
|
Cancer Epidemiol Biomarkers Prev
|
2009
|
1.17
|
35
|
Genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2) and risk of non-Hodgkin lymphoma.
|
Pharmacogenet Genomics
|
2006
|
1.12
|
36
|
Smoking, alcohol use, obesity, and overall survival from non-Hodgkin lymphoma: a population-based study.
|
Cancer
|
2010
|
1.12
|
37
|
Interleukin-6-related genotypes, body mass index, and risk of multiple myeloma and plasmacytoma.
|
Cancer Epidemiol Biomarkers Prev
|
2006
|
1.10
|
38
|
The role of genetic polymorphisms in environmental health.
|
Environ Health Perspect
|
2003
|
1.09
|
39
|
A case-control study of risk factors for invasive cervical cancer among U.S. women exposed to oncogenic types of human papillomavirus.
|
Cancer Epidemiol Biomarkers Prev
|
2004
|
1.08
|
40
|
A pooled investigation of Toll-like receptor gene variants and risk of non-Hodgkin lymphoma.
|
Carcinogenesis
|
2008
|
1.08
|
41
|
Invited Commentary: E Pluribus Unum for Epidemiology.
|
Am J Epidemiol
|
2015
|
1.07
|
42
|
Reproductive factors, exogenous hormone use and risk of lymphoid neoplasms among women in the National Institutes of Health-AARP Diet and Health Study Cohort.
|
Int J Cancer
|
2009
|
1.05
|
43
|
Sun exposure, vitamin D receptor gene polymorphisms and risk of non-Hodgkin lymphoma.
|
Cancer Causes Control
|
2007
|
1.04
|
44
|
Lymphoid malignancies in U.S. Asians: incidence rate differences by birthplace and acculturation.
|
Cancer Epidemiol Biomarkers Prev
|
2011
|
1.03
|
45
|
Seroprevalence and correlates of human papillomavirus 16/18 seropositivity among young women in Costa Rica.
|
Sex Transm Dis
|
2010
|
1.02
|
46
|
Genetic variation in caspase genes and risk of non-Hodgkin lymphoma: a pooled analysis of 3 population-based case-control studies.
|
Blood
|
2009
|
1.01
|
47
|
Human papillomavirus load measured by Linear Array correlates with quantitative PCR in cervical cytology specimens.
|
J Clin Microbiol
|
2012
|
0.99
|
48
|
HPV16 variant lineage, clinical stage, and survival in women with invasive cervical cancer.
|
Infect Agent Cancer
|
2011
|
0.99
|
49
|
Impact of interleukin-10 polymorphisms (-1082 and -3575) on the survival of patients with lymphoid neoplasms.
|
Haematologica
|
2007
|
0.98
|
50
|
Genetic variation in Th1/Th2 pathway genes and risk of non-Hodgkin lymphoma: a pooled analysis of three population-based case-control studies.
|
Br J Haematol
|
2011
|
0.98
|
51
|
Confirmation of the reported association of clonal chromosomal mosaicism with an increased risk of incident hematologic cancer.
|
PLoS One
|
2013
|
0.98
|
52
|
Common variants in genes that mediate immunity and risk of multiple myeloma.
|
Int J Cancer
|
2007
|
0.96
|
53
|
Common variation in genes related to innate immunity and risk of adult glioma.
|
Cancer Epidemiol Biomarkers Prev
|
2009
|
0.96
|
54
|
DRD2 genetic variation in relation to smoking and obesity in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
|
Pharmacogenet Genomics
|
2006
|
0.96
|
55
|
Genotype frequency and F ST analysis of polymorphisms in immunoregulatory genes in Chinese and Caucasian populations.
|
Immunogenetics
|
2007
|
0.96
|
56
|
Incidence of lymphoid neoplasms by subtype among six Asian ethnic groups in the United States, 1996-2004.
|
Cancer Causes Control
|
2008
|
0.96
|
57
|
Body size and multiple myeloma mortality: a pooled analysis of 20 prospective studies.
|
Br J Haematol
|
2014
|
0.95
|
58
|
Risk of meningioma and common variation in genes related to innate immunity.
|
Cancer Epidemiol Biomarkers Prev
|
2010
|
0.94
|
59
|
Parents' ages at birth and risk of adult-onset hematologic malignancies among female teachers in California.
|
Am J Epidemiol
|
2010
|
0.94
|
60
|
Evaluation of candidate methylation markers to detect cervical neoplasia.
|
Gynecol Oncol
|
2007
|
0.94
|
61
|
Single nucleotide polymorphisms in the PRDX3 and RPS19 and risk of HPV persistence and cervical precancer/cancer.
|
PLoS One
|
2012
|
0.93
|
62
|
Clinical and pathological heterogeneity of cervical intraepithelial neoplasia grade 3.
|
PLoS One
|
2012
|
0.93
|
63
|
A pooled analysis of three studies evaluating genetic variation in innate immunity genes and non-Hodgkin lymphoma risk.
|
Br J Haematol
|
2011
|
0.93
|
64
|
Heterogeneity of high-grade cervical intraepithelial neoplasia related to HPV16: implications for natural history and management.
|
Int J Cancer
|
2012
|
0.93
|
65
|
Organochlorine exposure, immune gene variation, and risk of non-Hodgkin lymphoma.
|
Blood
|
2008
|
0.92
|
66
|
Vegetables- and antioxidant-related nutrients, genetic susceptibility, and non-Hodgkin lymphoma risk.
|
Cancer Causes Control
|
2008
|
0.91
|
67
|
Personal history of diabetes, genetic susceptibility to diabetes, and risk of brain glioma: a pooled analysis of observational studies.
|
Cancer Epidemiol Biomarkers Prev
|
2013
|
0.91
|
68
|
Associations of non-Hodgkin Lymphoma (NHL) risk with autoimmune conditions according to putative NHL loci.
|
Am J Epidemiol
|
2015
|
0.91
|
69
|
Accuracy of cervical specimens obtained for biomarker studies in women with CIN3.
|
Gynecol Oncol
|
2009
|
0.91
|
70
|
Relationship between interferon regulatory factor 4 genetic polymorphisms, measures of sun sensitivity and risk for non-Hodgkin lymphoma.
|
Cancer Causes Control
|
2009
|
0.90
|
71
|
Molecular characteristics of diffuse large B-cell lymphoma in human immunodeficiency virus-infected and -uninfected patients in the pre-highly active antiretroviral therapy and pre-rituximab era.
|
Leuk Lymphoma
|
2013
|
0.89
|
72
|
Polymorphisms in DNA repair genes and risk of non-Hodgkin lymphoma in a pooled analysis of three studies.
|
Br J Haematol
|
2010
|
0.89
|
73
|
PRRC2A and BCL2L11 gene variants influence risk of non-Hodgkin lymphoma: results from the InterLymph consortium.
|
Blood
|
2012
|
0.89
|
74
|
Genetic admixture and population substructure in Guanacaste Costa Rica.
|
PLoS One
|
2010
|
0.88
|
75
|
Common genetic variation in TP53 and risk of human papillomavirus persistence and progression to CIN3/cancer revisited.
|
Cancer Epidemiol Biomarkers Prev
|
2009
|
0.88
|
76
|
Alcohol consumption over time and risk of lymphoid malignancies in the California Teachers Study cohort.
|
Am J Epidemiol
|
2010
|
0.88
|
77
|
Known glioma risk loci are associated with glioma with a family history of brain tumours -- a case-control gene association study.
|
Int J Cancer
|
2012
|
0.88
|
78
|
Determinants of human papillomavirus-negative, low-grade squamous intraepithelial lesions in the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesions triage study (ALTS).
|
Cancer
|
2005
|
0.87
|
79
|
Risk factors for non-Hodgkin lymphoma subtypes defined by histology and t(14;18) in a population-based case-control study.
|
Int J Cancer
|
2010
|
0.87
|
80
|
Association between adult height, genetic susceptibility and risk of glioma.
|
Int J Epidemiol
|
2012
|
0.86
|
81
|
Oral contraceptives, menopausal hormone therapy use and risk of B-cell non-Hodgkin lymphoma in the California Teachers Study.
|
Int J Cancer
|
2010
|
0.85
|
82
|
Smoking, variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma: a pooled analysis within the InterLymph consortium.
|
Cancer Causes Control
|
2012
|
0.85
|
83
|
Joint effects between five identified risk variants, allergy, and autoimmune conditions on glioma risk.
|
Cancer Causes Control
|
2013
|
0.85
|
84
|
Cigarette smoking, passive smoking, and non-Hodgkin lymphoma risk: evidence from the California Teachers Study.
|
Am J Epidemiol
|
2011
|
0.85
|
85
|
Tubal ligation frequency in Oklahoma women with cervical cancer.
|
Gynecol Oncol
|
2012
|
0.83
|
86
|
Reproducibility of linear array for human papillomavirus genotyping.
|
J Clin Microbiol
|
2012
|
0.82
|
87
|
Comparison of human papillomavirus distribution in cytologic subgroups of low-grade squamous intraepithelial lesion.
|
Cancer
|
2006
|
0.81
|
88
|
Dietary phytocompounds and risk of lymphoid malignancies in the California Teachers Study cohort.
|
Cancer Causes Control
|
2010
|
0.81
|
89
|
Common single nucleotide polymorphisms in immunoregulatory genes and multiple myeloma risk among women in Connecticut.
|
Am J Hematol
|
2010
|
0.81
|
90
|
SLC6A3 and body mass index in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.
|
BMC Med Genet
|
2009
|
0.80
|
91
|
Evaluation of a multiplex panel of immune-related markers in cervical secretions: a methodologic study.
|
Int J Cancer
|
2013
|
0.80
|
92
|
Immunostaining to identify molecular subtypes of diffuse large B-cell lymphoma in a population-based epidemiologic study in the pre-rituximab era.
|
Int J Mol Epidemiol Genet
|
2011
|
0.79
|
93
|
Human leukocyte antigen class I and II alleles and overall survival in diffuse large B-cell lymphoma and follicular lymphoma.
|
ScientificWorldJournal
|
2011
|
0.78
|
94
|
Inherited genetic variation and overall survival following follicular lymphoma.
|
Am J Hematol
|
2012
|
0.77
|
95
|
LIM domain only 2 protein expression, LMO2 germline genetic variation, and overall survival in diffuse large B-cell lymphoma in the pre-rituximab era.
|
Leuk Lymphoma
|
2012
|
0.77
|
96
|
Re: Hair dye use, genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma, author response.
|
Carcinogenesis
|
2008
|
0.77
|
97
|
Medication use and multiple myeloma risk in Los Angeles County.
|
Cancer Causes Control
|
2014
|
0.76
|
98
|
Risk of cervical intraepithelial neoplasia 2+ among women with a history of previous treatment for cervical intraepithelial neoplasia: ASCUS and LSIL Pap smears after treatment.
|
J Low Genit Tract Dis
|
2011
|
0.75
|
99
|
"Sip volume" as a quality indicator in liquid-based cervical cytology.
|
Cancer
|
2006
|
0.75
|
100
|
Factors associated with reduced accuracy in Papanicolaou tests for patients with invasive cervical cancer.
|
Cancer Cytopathol
|
2014
|
0.75
|
101
|
The Ninth Annual American Association of cancer research international conference on frontiers in cancer prevention research.
|
Cancer Prev Res (Phila)
|
2011
|
0.75
|